Kalemkerian GP - Search Results

1

Real-world comparison of immune checkpoint inhibitors in non-small cell lung cancer following platinum-based chemotherapy.

Weis TM, Hough S, Reddy HG, Daignault-Newton S, Kalemkerian GP. Weis TM, et al. Among authors: kalemkerian gp. J Oncol Pharm Pract. 2020 Apr;26(3):564-571. doi: 10.1177/1078155219855127. Epub 2019 Jun 25. J Oncol Pharm Pract. 2020. PMID: 31238808

2

Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer.

Ali MA, Kraut MJ, Valdivieso M, Herskovic AM, Du W, Kalemkerian GP. Ali MA, et al. Among authors: kalemkerian gp. Lung Cancer. 1998 Oct;22(1):39-44. doi: 10.1016/s0169-5002(98)00064-6. Lung Cancer. 1998. PMID: 9869106 Clinical Trial.

3

Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer.

Kalemkerian GP, Belzer K, Wozniak AJ, Gaspar LE, Valdivieso M, Kraut MJ. Kalemkerian GP, et al. Lung Cancer. 1999 Sep;25(3):175-82. doi: 10.1016/s0169-5002(99)00060-4. Lung Cancer. 1999. PMID: 10512128 Clinical Trial.

4

Therapeutic advances in small cell lung cancer.

Worden FP, Kalemkerian GP. Worden FP, et al. Among authors: kalemkerian gp. Expert Opin Investig Drugs. 2000 Mar;9(3):565-79. doi: 10.1517/13543784.9.3.565. Expert Opin Investig Drugs. 2000. PMID: 11060696 Review.

5

Unusual presentations of lung cancer: Case 1. Diabetes insipidus as the initial manifestation of non-small-cell lung cancer.

Reddy P, Kalemkerian GP. Reddy P, et al. Among authors: kalemkerian gp. J Clin Oncol. 2002 Dec 1;20(23):4597-8. doi: 10.1200/JCO.2002.20.23.4597. J Clin Oncol. 2002. PMID: 12454118 No abstract available.

6

Unusual presentations of lung cancer: Case 2. Adrenal insufficiency as the initial manifestation of non-small-cell lung cancer.

Sirachainan E, Kalemkerian GP. Sirachainan E, et al. Among authors: kalemkerian gp. J Clin Oncol. 2002 Dec 1;20(23):4598-600. doi: 10.1200/JCO.2002.20.23.4598. J Clin Oncol. 2002. PMID: 12454119 No abstract available.

7

False-positive findings with positron emission tomography in the staging of non-small-cell lung cancer.

Schneider BJ, Avram AM, Shulkin BL, Kalemkerian GP. Schneider BJ, et al. Among authors: kalemkerian gp. Clin Adv Hematol Oncol. 2005 Jul;3(7):571-3. Clin Adv Hematol Oncol. 2005. PMID: 16167039 No abstract available.

8

High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.

Kong FM, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA. Kong FM, et al. Among authors: kalemkerian gp. Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):324-33. doi: 10.1016/j.ijrobp.2005.02.010. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168827

9

Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.

Kong FM, Hayman JA, Griffith KA, Kalemkerian GP, Arenberg D, Lyons S, Turrisi A, Lichter A, Fraass B, Eisbruch A, Lawrence TS, Ten Haken RK. Kong FM, et al. Among authors: kalemkerian gp. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1075-86. doi: 10.1016/j.ijrobp.2006.01.051. Epub 2006 May 2. Int J Radiat Oncol Biol Phys. 2006. PMID: 16647222

10

Palliative chemotherapy for non-small cell lung cancer: a measured dose of reality.

Kalemkerian GP. Kalemkerian GP. J Support Oncol. 2007 Jan;5(1):27-8. J Support Oncol. 2007. PMID: 17265783 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters